stockrowBioAge Labs, Inc. (BIOA) vs Canopy Growth Corporation (CGC)
- BioAge Labs, Inc. BIOA 5.54 −6.89%
- Canopy Growth Corporation CGC 0.68 −9.33%
BioAge Labs, Inc. and Canopy Growth Corporation are both Drug Manufacturers Specialty & Generic companies. Canopy Growth Corporation is the larger, with a market value of $283.5M against $254.3M — 1.1× the size. Canopy Growth Corporation has the higher net margin (−80.4% vs −1,253.6%) and the higher return on invested capital (−17.2% vs −21.8%). Across the 16 metrics below, Canopy Growth Corporation leads on 10 and BioAge Labs, Inc. on 6.
Valuation
Profitability
| Metric | BIOA | CGC | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | 25.16% | 53.51% |
| Operating margin | (1,401.81%) | (54.89%) | 0.00% |
| Net margin | (1,253.60%) | (80.39%) | (2.45%) |
| Free cash flow margin | (2,997.41%) | (28.34%) | 0.00% |
| Return on equity | (34.56%) | (40.14%) | (0.80%) |
| Return on assets | (32.05%) | (23.54%) | (1.67%) |
| Return on invested capital | (21.75%) | (17.19%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack